Roble, Belko & Company, Inc Pear Therapeutics, Inc. Transaction History

Roble, Belko & Company, Inc

  • $583 Million
  • Q1 2024

A detailed history of Roble, Belko & Company, Inc transactions in Pear Therapeutics, Inc. stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 4,502 shares of PEAR stock, worth $45. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,502
Previous 4,502 -0.0%
Holding current value
$45
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
BUY
$4.98 - $10.0 $22,419 - $45,020
4,502 New
4,502 $28,000

Others Institutions Holding PEAR

# of Institutions
3
Shares Held
23M
Call Options Held
0
Put Options Held
0
View Full List

About Pear Therapeutics, Inc.

PEAR Quotes by TradingView
  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Roble, Belko & Company, Inc Portfolio

Follow Roble, Belko & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email